JP Morgan initiated coverage on Viking Therapeutics with a new price target

9/11/24 7:46:26 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

JP Morgan initiated coverage of Viking Therapeutics with a rating of Overweight and set a new price target of $80.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$VKTX

Date	Price Target	Rating	Analyst
4/29/2025	$104.00	Overweight	Cantor Fitzgerald
4/8/2025	$30.00	Neutral	Goldman
2/13/2025	$102.00	Sector Outperform	Scotiabank
2/7/2025	$38.00	Neutral	Citigroup
12/2/2024		Overweight	Piper Sandler
11/22/2024	$109.00	Buy	B. Riley Securities
11/4/2024	$90.00 → $102.00	Buy	H.C. Wainwright
9/11/2024	$80.00	Overweight	JP Morgan